Sort
30,917 grants matching “tumor microenvironment”
Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer
$689,468Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy
$689,330Yu Leo Lei · University Of Michigan At Ann Arbor · U01 · FY2023 · DE
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
$689,255Benjamin G. Neel · New York University School Of Medicine · R01 · FY2023 · CA
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
$689,255Benjamin G. Neel · New York University School Of Medicine · R01 · FY2022 · CA
Novel targeted therapy for treating Ovarian Cancer
$689,000Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2022 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$688,917Kathryn Miller-Jensen · Yale University · U01 · FY2021 · CA
Defining the role of cytomegalovirus in glioblastoma therapies
$688,910Sean Edward Lawler · Brown University · R01 · FY2022 · CA
Clinical trials employing cancer vaccine combination therapies
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
$688,666Shrikant Anant · University Of Kansas Medical Center · R01 · FY2017 · CA
Training Program in Basic Cancer Research
$688,528Maureen E Murphy · Wistar Institute · T32 · FY2021 · CA
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
$688,403Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2018 · CA
Cancer Center Administration
$688,399Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2023 · CA
Translational Application of Magnetic Hyperthermia Therapy with Adjuvant Therapies for Glioblastoma
$688,395Constantinos George Hadjipanayis · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
A physical sciences approach to investigate the role of exosomes in metastatic progression
$688,299Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2021 · CA
Role and Regulation of Asparagine in Colorectal Cancer
$688,092Caroline Helen Johnson · Yale University · R01 · FY2025 · CA
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$688,018Benjamin G. Neel · New York University School Of Medicine · R01 · FY2022 · CA
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$688,018Benjamin G. Neel · New York University School Of Medicine · R01 · FY2023 · CA
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
$688,005Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
$687,979Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment
$687,824Lan Zhou · Methodist Hospital Research Institute · R01 · FY2024 · CA
Understanding and Targeting Transcriptional Master Regulators in Hepatocellular Carcinoma
$687,679Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2025 · CA
Mapping Immune Contexture and Crosstalk with Tumor Cells At GBM Margin
$687,394Hongyan Jenny Zou · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · NS
Interstitial fluid flow in Alzheimer's Disease Progression
$687,348Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · AG
Probabilistic Multiscale Modeling of the Tumor Microenvironment
$687,286Wesley Tansey · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA